Stock HAE HAEMATO AG
Add to a list
To use this feature you must be a member
Log inSign up

Company HAEMATO AG Xetra

Equities

HAE

DE000A289VU3

Pharmaceuticals

End-of-day quote Xetra
Other stock markets
 06:00:00 2024-02-04 pm EST 		5-day change 1st Jan Change
26.2 EUR -0.76% Intraday chart for HAEMATO AG -1.50% -5.76%
2021 HAEMATO AG Provides Earnings Guidance for the Year 2021 CI
2021 HAEMATO AG Announces Board Changes CI

Business Summary

Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan. It also imports medicines from within the European Economic Area in form of parallel imports and re-imports. The Company's subsidiaries are Haemato Pharm GmbH, Heamato Med GmbH, Castell Pharma BV, Sanate GmbH and Heamato Asia Co Ltd. Customers can order medicine through phone, fax and e-mail, among others.

Sales per Business

EUR in Million2021Weight2022Weight Delta
Specialty Pharma
82.9 %
220 77.1 % 206 82.9 % -6.47%
Lifestyle and Aesthetics
17.1 %
65 22.9 % 42 17.1 % -34.79%

Sales per region

EUR in Million2021Weight2022Weight Delta
Germany
100.0 %
285 100.0 % 248 100.0 % -12.95%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,229,307 5,212,106 ( 99.67 %) 17,201 ( 0.3289 %) 99.67 %

Shareholders

NameEquities%Valuation
M1 KLINIKEN AG
68.30 %
3,571,617 68.30 % 64 M €
Asset Value Investors Ltd.
0.9959 %
52,077 0.9959 % 928 012 €
Matejka & Partner Asset Management GmbH
0.2406 %
12,580 0.2406 % 224 176 €
Viktoria Emissionshaus & Immobilien GmbH
0.1598 %
8,354 0.1598 % 148 868 €
PEH Wertpapier AG (Austria)
0.1503 %
7,860 0.1503 % 140 065 €
Cominvest Asset Management GmbH
0.1434 %
7,500 0.1434 % 133 650 €
Do Investment AG
0.1147 %
6,000 0.1147 % 106 920 €
Chart AG
0.0199 %
1,040 0.0199 % 18 533 €

Company contact information

Haemato AG

Lilienthalstrasse 3a

12529, Schönefeld

+49 30 897 30 86 70

http://haemato.de
address HAEMATO AG(HAE)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for HAEMATO AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
21.4 EUR
Average target price
33 EUR
Spread / Average Target
+54.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MERCK KGAA Stock Merck KGaA
+5.31% 70.44B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.97% 8.94B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-16.83% 4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+43.48% 4.5B
YUHAN CORPORATION Stock Yuhan Corporation
+3.20% 3.85B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-21.36% 2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-29.67% 2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+8.38% 1.96B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+3.90% 1.65B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HAEK Stock
  4. HAE Stock
  5. Company HAEMATO AG